GMRS · GMR Solutions Inc.
Market Cap
$685.54M
Shares
54.02M
GMRS metrics
34 of 114 screener metrics currently available.
Market overview
2 metricsShare price
$12.79
Market cap
$685.54M
Price action
19 metricsPrice change (1W)
+2.1%
Price change (30D)
-0.2%
Price change (3M)
+22.2%
Price change (6M)
—
Price change (YTD)
—
Price change (1Y)
—
Trailing year
Price change (5Y)
—
52-week high
—
52-week low
—
Change from 52-week high
—
Change from 52-week low
—
Annualized volatility
68.5%
Beta
—
RSI (14D)
48.8
Price vs SMA 50
-4.0%
Price vs SMA 200
—
Avg volume (3M)
738,667
Relative volume
1.1
Average dollar volume
$9.89M
Company
3 metricsSector
Healthcare
Industry
Medical Care Facilities
Shares outstanding
54.02M
Valuation
12 metricsP / E (TTM)
—
Trailing earnings
PEG ratio
—
EV / revenue
—
EV / EBITDA
—
EV / EBIT
—
P / sales
—
P / book
0.9
reciprocal yield 115.1%
FCF yield
—
TTM · current market cap
Buyback yield
—
P / FCF
—
P / operating cash flow
—
Earnings yield
—
Historical valuation
8 metricsP / E historical average (3Y)
—
P / E historical average (5Y)
—
EV / revenue historical average (3Y)
—
EV / revenue historical average (5Y)
—
EV / EBIT historical average (3Y)
—
EV / EBIT historical average (5Y)
—
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—
Dividends & buybacks
7 metricsDividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
—
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—
Earnings calendar
2 metricsNext earnings
—
Last earnings
2026-08-13
Profitability
9 metricsGross margin
—
Operating margin
—
Trailing 12 months
Net margin
—
Gross profit (TTM)
—
Operating profit (TTM)
—
Net income (TTM)
—
Trailing 12 months
Diluted EPS (TTM)
—
FCF margin
—
Effective tax rate
—
Growth
11 metricsRevenue growth YoY
+3.3%
Year over year
Net income growth YoY
-135.0%
Revenue (TTM)
—
Trailing 12 months
EPS growth YoY
-781.5%
Shares change YoY
-57.7%
Year over year · fewer shares
Revenue CAGR (3Y)
—
Revenue CAGR (5Y)
—
EPS CAGR (3Y)
—
EPS CAGR (5Y)
—
FCF CAGR (3Y)
—
FCF CAGR (5Y)
—
Quality
14 metricsReturn on equity
—
Return on assets
—
Debt / equity
5.6
Current ratio
2.0
EBITDA (TTM)
—
Free cash flow (TTM)
—
Quick ratio
1.9
Interest coverage
—
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
−$3.93B
Latest balance sheet
Cash & equivalents
$420.00M
Total assets
$7.43B
Total debt
$4.42B
Cash flow & spend
7 metricsOperating cash flow (TTM)
—
Capital expenditures (TTM)
—
R&D (TTM)
—
SG&A (TTM)
—
Stock compensation (TTM)
—
R&D / revenue
—
Stock compensation / revenue
—
Ownership (13F)
3 metrics13F filers
61
13F filer change QoQ
+61
Institutional ownership
94.6%
Short interest
3 metricsShort interest
4.5%
Latest settlement · 2.6 days to cover
Days to cover
2.6d
Short-squeeze score
68 / 100
Insider activity
2 metricsNet insider buying (90D)
—
Insider-sentiment score
—
Risk flags
1 metricsGoing concern
—
Key facts
CIK
1898718
CUSIP
38013D106
13F (30d)
64 filings
61 filers
Visit website
Investor relations